Solventum Corp. Total Liabilities
Solventum Corp. total liabilities. Based on the latest financial reports, Solventum Corp. (SOLV) has total liabilities worth $9.44 Billion USD as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Solventum Corp. (SOLV) liquid assets ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Solventum Corp. (2021–2025)
Total liabilities of Solventum Corp. from 2021 to 2025. This chart illustrates how Solventum Corp.'s total liabilities have evolved over time, based on quarterly financial data.
Solventum Corp. Competitors by Total Liabilities
The table below lists competitors of Solventum Corp. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Assurant, Inc.
NYSE:AIZ
|
USA | $29.98 Billion |
|
METSO OUTOTEC UNS.ADR 1/2
F:M6QB
|
Germany | €4.44 Billion |
|
Evolution Gaming Group AB (publ)
F:E3G
|
Germany | €1.24 Billion |
|
Shenwan Hongyuan Group Co Ltd
SHE:000166
|
China | CN¥582.43 Billion |
|
Pershing Square Inc.
NYSE:PS
|
USA | $106.00 Million |
|
Euronext N.V.
PA:ENX
|
France | €322.90 Billion |
|
VERBUND AG
VI:VER
|
Austria | €7.10 Billion |
|
KT&G Corp
KO:033780
|
Korea | ₩5.37 Trillion |
Liability Composition Analysis (2021–2025)
This chart breaks down Solventum Corp.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see total assets of Solventum Corp..
Liquidity & Leverage Metrics
Solventum Corp. Total Liabilities Ratios Explained
Solventum Corp. total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.02 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.97 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.66 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Solventum Corp.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Solventum Corp. (2021–2025)
The table below shows the annual total liabilities of Solventum Corp. from 2021 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $9.24 Billion | -19.59% |
| 2024-12-31 | $11.50 Billion | +404.96% |
| 2023-12-31 | $2.28 Billion | +22.95% |
| 2022-12-31 | $1.85 Billion | -8.13% |
| 2021-12-31 | $2.02 Billion | -- |
About Solventum Corp.
Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates through three segments: Medsurg, Dental Solutions, and Health Information Systems. The Medsurg segment offers solutions, such as negative pressure wound therapy, advanced wound dressing… Read more